New Chair of Genomics Advisory Committee appointed by UK BioIndustry Association
Oxford, UK – 25 January 2023 – The UK BioIndustry Association (BIA) has announced PrecisionLife CEO and Co-founder, Dr Steve Gardner, as the new Chair of the national Genomics Advisory Committee. Dr Gardner will be joined by newly appointed Vice-Chair Danuta Jeziorska, CEO and Co-founder of Nucleome Therapeutics.
The Genomics Advisory Committee aims to influence and engage with the key strategic programmes that enable the UK to start, scale and build world-leading genomic businesses, providing a platform for discussion between genomic companies and collective input to relevant policy discussions.
Dr Gardner has over 30 years’ experience of developing and commercializing ground-breaking data science and informatics in the life sciences, healthcare, and agri-tech sectors.
In the role, Drs Gardner and Jeziorska will set the strategic direction of the committee and be a key interface between its members, the BIA board, and the UK government.
"It's an honour to Chair the BIA Genomics Advisory Committee at such an exciting and important time for genomics and techbio companies, both in the UK and on the global stage”, said Dr Gardner. “I look forward to working with Danuta, our committee members, the BIA and the broad community of UK genomics researchers on our shared vision to develop and promote the UK’s vibrant and innovative genomics ecosystem.”
Companies and organisations represented on the Committee include AstraZeneca, Bayer, Eagle Genomics, Illumina, IQVIA, Johnson & Johnson, Novartis, PrecisionLife, Roche, ThermoFisher Scientific, and the Wellcome Sanger Institute.
Further information on the BIA Genomics Advisory Committee